Strs Ohio grew its holdings in Neogen Co. (NASDAQ:NEOG) by 9.0% in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 17,000 shares of the company’s stock after buying an additional 1,400 shares during the quarter. Strs Ohio’s holdings in Neogen were worth $1,319,000 as of its most recent filing with the SEC.
Several other hedge funds have also made changes to their positions in NEOG. State of Tennessee Treasury Department grew its holdings in shares of Neogen by 0.6% in the 1st quarter. State of Tennessee Treasury Department now owns 28,659 shares of the company’s stock worth $1,920,000 after purchasing an additional 173 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its position in Neogen by 1.0% in the second quarter. Oregon Public Employees Retirement Fund now owns 21,137 shares of the company’s stock valued at $1,640,000 after buying an additional 200 shares in the last quarter. Quadrant Capital Group LLC grew its stake in Neogen by 17.6% during the fourth quarter. Quadrant Capital Group LLC now owns 1,436 shares of the company’s stock worth $90,000 after buying an additional 215 shares during the last quarter. Sunbelt Securities Inc. acquired a new stake in shares of Neogen during the fourth quarter worth approximately $4,220,000. Finally, Versant Capital Management Inc raised its stake in shares of Neogen by 256.2% in the first quarter. Versant Capital Management Inc now owns 374 shares of the company’s stock valued at $25,000 after acquiring an additional 269 shares during the last quarter. Institutional investors own 92.91% of the company’s stock.
In other Neogen news, VP Jason Warren Lilly sold 885 shares of the company’s stock in a transaction on Tuesday, May 5th. The shares were sold at an average price of $64.00, for a total transaction of $56,640.00. Following the completion of the sale, the vice president now owns 10,409 shares in the company, valued at approximately $666,176. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.70% of the company’s stock.
A number of research analysts have recently issued reports on NEOG shares. Stephens reiterated a “buy” rating and issued a $88.00 target price on shares of Neogen in a research note on Tuesday, July 14th. William Blair reiterated a “market perform” rating on shares of Neogen in a research note on Tuesday, July 21st. BidaskClub upgraded shares of Neogen from a “hold” rating to a “buy” rating in a research note on Friday, June 26th. TheStreet upgraded shares of Neogen from a “c” rating to a “b-” rating in a research report on Monday, May 11th. Finally, Roth Capital boosted their price objective on shares of Neogen from $67.00 to $75.00 and gave the stock a “neutral” rating in a research report on Thursday, July 23rd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $75.67.
Shares of Neogen stock opened at $76.77 on Friday. The firm has a fifty day moving average of $75.03 and a two-hundred day moving average of $68.27. The stock has a market capitalization of $3.97 billion, a price-to-earnings ratio of 67.94, a PEG ratio of 6.18 and a beta of 0.75. Neogen Co. has a 52 week low of $48.91 and a 52 week high of $80.84.
Neogen (NASDAQ:NEOG) last issued its earnings results on Tuesday, July 21st. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.30 by $0.01. The company had revenue of $109.10 million during the quarter, compared to analysts’ expectations of $112.15 million. Neogen had a net margin of 14.22% and a return on equity of 8.53%. The business’s revenue for the quarter was down .8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.30 EPS. On average, research analysts forecast that Neogen Co. will post 1.22 earnings per share for the current fiscal year.
Neogen Company Profile
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.
Further Reading: What does cost of debt say about a company’s financial health?
Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Co. (NASDAQ:NEOG).
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.